亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

無錫同創生物科技有限公司  

辣根過氧化物酶,5-溴-4氯-3吲哚-神經氨酸,吡咯酯等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:張倩
  • 電話:13655185676
  • 郵件:wuxitongchuang@yahoo.cn
  • 傳真:0510-85899582
  • QQ:1760363918
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 4-氨基-3-肼-5-巰基-1,2,4-三唑
4-氨基-3-肼-5-巰基-1,2,4-三唑
單價 面議對比
詢價 暫無
發貨 江蘇無錫市付款后3天內
品牌 MRC
過期 長期有效
更新 2024-01-10 11:53
 
詳細信息

基本信息

 

中文名稱: AHMT(4-氨基-3-聯氨-5-疏基-1,2,4-三氮雜茂),>99.0%
中文別名: 4-氨基-3-肼基-5-巰基-1,2,4-三唑
英文名稱: 4amino3hydrazino5mercapto1 2 4triazol
英文別名: AHMT4Amino5hydrazino124triazole3thiol
純度: >99.0%
等級: AR
CAS號: 1750-12-5
分子式: C2H6N6S
分子量: 146.17

性能描述  

白色粉末

物理參數  

熔點:228~230 °C(分解)

用途說明  

測定甲醛和其它反應性化學品的專一試劑。HPLC中衍生中性單糖。
 
包裝規格
 
50G/100G/瓶
©2025 無錫同創生物科技有限公司 版權所有   技術支持:化工網   訪問量:36771  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |